2 Road Show Presentation The attached slide show was filed with the Securities and Exchange Commission as part of the amendment to Form 8-K filed by KBL Healthcare Acquisition Corp. II with the Securities and Exchange Commission on October 20, 2006 (“8-K Amendment No. 2”). KBL is holding presentations for certain of its stockholders, as well as other persons who might be interested in purchasing KBL’s securities, regarding its acquisition with Summer Infant, Inc. and affiliated companies, as described in the September 5, 2006 8-K filing as amended by 8-K Amendment No. 1 filed September 19, 2006 and 8-K Amendment No. 2. The attached slide show, as well as the September 5, 2006 filing as amended by 8-K Amendments are being distributed to attendees of these presentations. Earlybird Capital, Inc. ("EBC"), the managing underwriter of KBL Healthcare's initial public offering ("IPO") consummated in April 2005, is assisting KBL Healthcare in these efforts without charge, other than the reimbursement of its out-of-pocket expenses, although EBC will be paid a cash fee at the closing of the acquisition equal to one percent (1%) of the consideration paid in the acquisition. KBL Healthcare and its directors and executive officers and EBC may be deemed to be participants in the solicitation of proxies for the special meeting of KBL Healthcare stockholders to be held to approve the acquisition. Stockholders of KBL Healthcare and other interested persons are advised to read, when available, KBL Healthcare's preliminary Proxy Statement and definitive Proxy Statement in connection with KBL Healthcare's solicitation of proxies for the special meeting because these proxy statements will contain important information. Such persons can also read KBL Healthcare's final Prospectus, dated April 21, 2005, for a description of the security holdings of KBL Healthcare’s officers and directors and of EBC and their respective interests in the successful consummation of this business combination. The definitive Proxy Statement will be mailed to stockholders as of a record date to be established for voting on the acquisition. Stockholders will also be able to obtain a copy of the definitive Proxy Statement, without charge, by directing a request to: KBL Healthcare Acquisition Corporation II, 757 3rd Ave, New York, NY 10017. The preliminary Proxy Statement and definitive Proxy Statement, once available, and the final Prospectus can also be obtained, without charge, at the Securities and Exchange Commission's internet site (Http://www.sec.gov). |